Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01313910 · ClinicalTrials.gov registry record · Early Phase 1
CCRC: A Project of the Treatment of HIV Enteropathy With ImmunoLin® Supplements
A Early Phase 1 study, sponsored by University of California, Davis.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 8
- Enrollment target
NCT01313910 is a Early Phase 1 study that has completed, run by University of California, Davis. The registered enrollment target is 8 participants.
The verdict
NCT01313910, a Early Phase 1 study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of the study is to see if ImmunoLin® will reduce the frequency of bowel movements and gastrointestinal (GI) symptoms in HIV volunteers with persistent GI symptoms. The study will also examine the effect of ImmunoLin® on the bacteria in the gut and the immune system in gut tissue as well as in the blood.
Interventions
- DIETARY_SUPPLEMENT Immunolin®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-08 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01313910
The ClinicalTrials.gov registry entry for NCT01313910 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Immunolin® is the first listed.
NCT01313910 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01313910 about?
NCT01313910 is a clinical study titled "CCRC: A Project of the Treatment of HIV Enteropathy With ImmunoLin® Supplements". The purpose of the study is to see if ImmunoLin® will reduce the frequency of bowel movements and gastrointestinal (GI) symptoms in HIV volunteers with persistent GI symptoms. The study will also examine the effect of ImmunoLin® on the bacteria in the gut and the immune system in gut tissue as well ...
What is the current status of trial NCT01313910?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 8 participants. The study started on 2011-03. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01313910?
The interventions under investigation include: Immunolin® (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01313910?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.